Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide

. 2023 Apr 01 ; 46 (4) : e89-e91.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid36716004

Adelaide Bariatric Centre Flinders Medical Centre Bedford Park Australia

Atrium Medical Center Parkstad Heerlen the Netherlands

Catharina Hospital Eindhoven the Netherlands

Department of Gastroenterology and Hepatology Princess Alexandra Hospital Woolloongabba Australia

Department of Pediatric Endocrinology Diabetes and Metabolic Diseases University Children's Hospital Ljubljana Slovenia

Diabetes and Endocrinology Guy's and St Thomas' Hospital London U K

Diabetes and Endocrinology Sandwell and West Birmingham Hospitals National Health Service Trust Birmingham U K

Diabetes Centre Institute for Clinical and Experimental Medicine Praha Czech Republic

Diabetes Diakonissensanstalt Emmaus Niesky Niesky Germany

Diabetes Endocrinology and Clinical Pharmacology University of Glasgow Glasgow U K

Diabetes Research Group Division of Diabetes and Nutritional Sciences King's College London London U K

Division of Endocrinology and Diabetology Department of Medicine 2 University Hospital of Freiburg Freiburg Germany

Endokrinologie und Diabetologie Universitätsklinikum Hamburg Eppendorf Ringgold Hamburg Germany

Epworth Centre for Bariatric Surgery Richmond Australia

Gastroenterology Imperial College London London U K

Gastroenterology Manchester University National Health Service Foundation Trust Manchester U K

Gastroenterology Tel Aviv Sourasky Medical Center Tel Aviv Israel

General Surgery Maastricht UMC Maastricht the Netherlands

Internal Medicine Division of Endocrinology and Diabetology Interdisciplinary Metabolic Medicine Trials Unit Medical University of Graz Graz Austria

Medical Faculty University of Ljubljana Ljubljana Slovenia

Metabolic and Bariatric Surgery Maastricht UMC Maastricht the Netherlands

Specialized Center for Obesity and Diabetes Hospital Alemão Oswaldo Cruz São Paulo Brazil

Surgery Calvary North Adelaide Hospital Adelaide Australia

Surgery University Hospital Southampton National Health Service Foundation Trust Southampton U K

Sydney Adventist Hospital Wahroonga Australia

Wakefield Clinic Adelaide Australia

Zuyderland Medical Centre Heerlen Heerlen the Netherlands

Zobrazit více v PubMed

International Diabetes Federation . Diabetes around the world in 2021. In: IDF Diabetes Atlas, 10th ed. Brussels, Belgium, International Diabetes Federation, 2021. Accessed 14 October 2022. Available from https://diabetesatlas.org/

Jirapinyo P, Haas AV, Thompson CC. Effect of the duodenal-jejunal bypass liner on glycemic control in patients with type 2 diabetes with obesity: a meta-analysis with secondary analysis on weight loss and hormonal changes. Diabetes Care 2018;41:1106–1115 PubMed

Ryder REJ, Irwin SP, Burbridge W, et al. . The United Kingdom’s first NHS EndoBarrier service for advanced diabesity: 1-year outcomes for all 62 treated patients. Br J Diabetes 2019;19:110–117

Ryder REJ, Yadagiri M, Burbridge W, et al. . Duodenal-jejunal bypass liner for treatment of type 2 diabetes and obesity: 4-year outcomes in the first National Health Service (NHS) EndoBarrier service. Br J Diabetes 2022;22:82–86 PubMed PMC

GI Dynamics . EndoBarrier system pivotal trial (Rev E) (STEP-1). In: ClinicalTrials.gov. Bethesda, MD, National Library of Medicine, 2000. NLM Identifier: NCT04101669. Accessed 14 October 2022. Available from https://clinicaltrials.gov/ct2/show/NCT04101669

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...